Alternative Factors in Possible Involvement of Coronary Microvascular Dysfunction in Older Patients with HFpEF

Shiro Hoshida1, Tetsuya Watanabe1, Nobutaka Masunaga1

  • 1Department of Cardiovascular Medicine, Yao Municipal Hospital, 1-3-1 Ryuge-cho, Yao 581-0069, Japan.

PubMed

Insights

In elderly patients with heart failure with preserved ejection fraction (HFpEF) and no coronary artery disease, left ventricular hypertrophy (LVH) and diastolic blood pressure (dBP) are key factors influencing prognosis. Lower dBP in LVH patients indicates higher mortality risk.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Geriatrics

Background:

  • Coronary microvascular dysfunction (CMD) is linked to heart failure with preserved ejection fraction (HFpEF).
  • Assessing CMD invasively is challenging in elderly HFpEF patients, and noninvasive criteria are unclear.
  • Identifying alternative factors for CMD involvement in HFpEF progression and prognosis is crucial.

Purpose of the Study:

  • To identify alternative factors related to coronary microvascular dysfunction (CMD) in the progression and prognosis of heart failure with preserved ejection fraction (HFpEF).
  • To investigate the roles of left ventricular hypertrophy (LVH) and diastolic blood pressure (dBP) in elderly HFpEF patients without coronary artery disease (CAD).

Main Methods:

  • Analysis of 607 elderly patients hospitalized for acute decompensated HFpEF without a history of CAD.
  • Utilized blood tests and transthoracic echocardiography.
  • Focused on left ventricular hypertrophy (LVH) and diastolic blood pressure (dBP) as key variables.

Main Results:

  • Patients with LVH exhibited reduced diastolic function and lower atrial fibrillation (AF) incidence.
  • In LVH patients, lower dBP was associated with higher all-cause mortality, reduced renal function, and elevated C-reactive protein.
  • A comprehensive diastolic functional index (diastolic elastance/arterial elastance) was a significant prognostic indicator, outperforming E/e'.

Conclusions:

  • Left ventricular hypertrophy (LVH) and diastolic blood pressure (dBP) are clinically significant factors in elderly HFpEF patients without a history of CAD.
  • Diastolic elastance/arterial elastance serves as a valuable prognostic index in this patient group.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394